Journal of Lipid Research, Vol. 21, 35-43, January 1980
Copyright © 1980 by Lipid Research, Inc.

Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short term feeding of chenodeoxycholic and ursodeoxycholic acid

N. Carulli , M. Ponz De Leon , F. Zironi , A. Pinetti , A. Smerieri , R. Iori , and P. Loria

Istituti di Clinica Medica, Clinica Chirurgica e Chimica Organica, Universita di Modena, Italy

The activity of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase and 7-hydroxylase, the enzymes controlling the rate of hepatic synthesis, respectively, of cholesterol and bile acids, and the microsomal cholesterol content were evaluated in 25 patients with cholesterol gallstones and 17 subjects without gallstones. The same quantities were estimated in 16 additional patients with gallstones given chenodeoxycholic (CDCA) or ursodeoxycholic acid (UDCA) at a dose of 15 mg/kg per day in order to investigate the comparative effect of a short term (7 days) administration of the two bile acids on the hepatic sterol metabolism. As compared to the controls, subjects with gallstones exhibited a 36% decrease of 7-hydroxylase (26.8 ± 6.2 versus 41.7 ± 4.2 pmol/min per mg protein) and a 24% increase of the microsomal cholesterol (78.7 ± 15.3 versus 63.1 ± 18.1 nmol/mg protein). Although higher in the gallstone patients, the activity of HMG-CoA reductase did not differ significantly in the two groups of subjects. Administration of CDCA and UDCA changed the bile acid pool composition so that the fed bile acid predominated in the bile (mean CDCA 73% and mean UDCA 54%). Bile lipid composition did not appreciably change. In the eight subjects treated with CDCA the activity of HMG-CoA reductase was reduced to 45% of the value of untreated subjects (27.9 ± 14.5 versus 63.5 ± 25.3 pmol/min per mg protein) whereas in the eight subjects treated with UDCA the same enzyme showed a twofold increase (123.5 ± 20.9). In the treated groups 7-hydroxylase activity was somewhat decreased but the values did not differ significantly from those of the untreated subjects. Microsomal cholesterol content decreased with CDCA (64.8 ± 11.6 nmol/mg protein) as well as with UDCA (59.1 ± 10.1) treatment; however in the latter the difference attained statistical significance (P < 0.05). Altogether the results would suggest that in the liver of patients with gallstones the conversion of cholesterol to bile acids is somewhat reduced, and that changing the bile acid pool composition, by exogenous bile acid feeding, has disparate effects on hepatic cholesterol synthesis. The findings could represent the acute changes produced by bile acid feeding, however they could imply that the effects of two bile acids in dissolving cholesterol gallstones might not be related only to the changes in hepatic sterol metabolism.—Carulli, N., M. Ponz De Leon, F. Zironi, A. Pinetti, A. Smerieri, R. Iori, and P. Loria. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short term feeding of chenodeoxycholic and ursodeoxycholic acid.

Supplementary key words HMG-CoA reductase • 7-hydroxylase • microsomal cholesterol

Submitted on January 29, 1979
Revised on June 19, 1979
Accepted on September 12, 1979

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Z.-Y. Jiang, P. Parini, G. Eggertsen, M. A. Davis, H. Hu, G.-J. Suo, S.-D. Zhang, L. L. Rudel, T.-Q. Han, and C. Einarsson Increased expression of LXR{alpha}, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients J. Lipid Res., February 1, 2008; 49(2): 464 - 472. [Abstract] [Full Text] [PDF]

				D. Q-H. Wang and S. Tazuma Effect of {beta}-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice J. Lipid Res., November 1, 2002; 43(11): 1960 - 1968. [Abstract] [Full Text] [PDF]

				M. Rudling, B. Angelin, L. Stahle, E. Reihner, S. Sahlin, H. Olivecrona, I. Bjorkhem, and C. Einarsson Regulation of Hepatic Low-Density Lipoprotein Receptor, 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, and Cholesterol 7{alpha}-Hydroxylase mRNAs in Human Liver J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4307 - 4313. [Abstract] [Full Text] [PDF]

				G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]

				M. Bertolotti, M. Concari, P. Loria, N. Abate, A. Pinetti, M. E. Guicciardi, and N. Carulli Effects of Different Phenotypes of Hyperlipoproteinemia and of Treatment With Fibric Acid Derivatives on the Rates of Cholesterol 7{alpha}-Hydroxylation in Humans Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1064 - 1069. [Abstract] [Full Text]